Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials-Reference-Cited by-同舟云学术

Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials

Published:2005-03 Issue:1 Volume:7 Page:E143-E148
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Burstein Summer

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/aapsj070115.pdf

Reference30 articles.

1. Burstein S. Therapeutic Potential of Ajulemic Acid (CT-3): In: Grontenhermen F, Russo E, eds.Cannabis and Cannabinoids. Binghamton, NY: Haworth Press Inc; 2002;381–388.

2. Burstein SH. Ajulemic acid (CT3): a potent analog of the acid metabolites of THC.Curr Pharm Des. 2000;6:1339–1345.

3. Burstein SH. The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential.Pharmacol Ther. 1999;82:87–96.

4. Burstein SH, Karst M, Schneider U, Zurier RB. Ajulemic acid: a novel cannabinoid produces analgesia without a “high”.Life Sci. 2004;75:1513–1522.

5. Burstein S, Hunter SA, Latham V, Renzulli L. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.Experientia. 1987;43:402–403.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemistry and pharmacological aspects of furanoid cannabinoids and related compounds: Is furanoid cannabinoids open a new dimension towards the non-psychoactive cannabinoids?;European Journal of Medicinal Chemistry;2024-03

2. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists;Journal of Clinical Medicine;2022-01-22

3. Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010;Pharmaceutical Patent Analyst;2021-05

4. Le système de signalisation endocannabinoïde: structure, fonction, pharmacologie;Douleurs : Évaluation - Diagnostic - Traitement;2021-04

5. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses;Toxins;2021-02-05